CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.
about
CXCR3 in carcinoma progressionC-X-C ligand 10 and C-X-C receptor 3 status can predict tamoxifen treatment response in breast cancer patientsThe role of chemoattractant receptors in shaping the tumor microenvironment.Heme mediated STAT3 activation in severe malaria.Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.The emerging role of CXC chemokines and their receptors in cancer.STAT3 regulates MMP3 in heme-induced endothelial cell apoptosisThe heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal.Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosisPlasmodium-infected erythrocytes (pRBC) induce endothelial cell apoptosis via a heme-mediated signaling pathwayA novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation.HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms.Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation.microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells.A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.Differential regulation of pericyte function by the CXC receptor 3.Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck.Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHNThe role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.
P2860
Q26826928-ADCD5C97-D224-4F1D-BEF5-2946FA689605Q28383941-B1F5542A-4D07-47E1-A11C-4F8107746245Q33993124-A05C798C-56D2-472C-9745-3B6C6244C9B9Q34222365-6979B08D-D1E3-478D-8881-1A07ACFE55E2Q34231598-6B78EB46-1DE9-429F-8D14-445B665CAB91Q34263645-7146AAF1-CDF6-467E-9814-5A9587291FDBQ34963885-654BD031-C156-4787-8544-0472FDE08CD6Q35312808-C848E2F3-133F-45C9-925E-93CE749DB46CQ36379354-14208575-91FE-4EA1-A97E-E25343DFD253Q36659302-74E9EACB-6637-4095-8BB5-88BE93AEBA90Q37563373-D2C14671-A36B-4D28-873E-A2AEE61DA1E8Q37576115-EC4E6A77-0C4A-484D-9B9C-E70143E9C05AQ38292744-75C094FB-9B45-4062-A960-121283B72DFBQ38514782-A36C77C9-B62E-4E18-870D-A51B5CBAB0FFQ39242775-E2BF44CE-0DA1-457D-8E5A-51844F954EFCQ39332938-4DE2308F-3AA4-4827-8AD6-403F1D47E539Q39401151-A973FED7-09AE-4088-8430-FB70A254B451Q39455824-D6B6D96B-D427-49DF-AF05-B99B1CA2BA39Q40700201-37489D80-4D29-49FD-BCB0-54DC3D9200E9Q41628251-3BA6BEF3-313B-4B6A-AA95-196A7801E3E8Q42036348-8E987C09-8F77-4AA1-A79E-42AD187E8E55Q42355050-FB71E0B3-DF23-4F92-A080-C601A77315D8Q44449800-3AF5F236-F50B-47BE-ACE2-13474954F9BAQ49656814-ED88EDBF-7573-4992-9E45-3CA152A6D6A5Q50499077-763A48B1-62DB-4891-BE20-936264100277Q51560838-3C708310-07DA-4CF9-B529-CDCB4E920BB8
P2860
CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@ast
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@en
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@nl
type
label
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@ast
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@en
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@nl
prefLabel
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@ast
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@en
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@nl
P2093
P2860
P356
P1476
CXCR3-B can mediate growth-inh ...... xpression of heme oxygenase-1.
@en
P2093
Ana Maria Waaga-Gasser
Dipak Datta
Martin Gasser
Pallavi Banerjee
Soumitro Pal
P2860
P304
36842-36848
P356
10.1074/JBC.M110.170324
P407
P577
2010-09-20T00:00:00Z